Clinical Trial

Project SIRT6 Activator

Recruiting
View on ClinicalTrials.gov →
Summary
The global ageing population is increasingly affected by age-related diseases, which are challenging healthcare systems. Current treatments often extend lifespan without improving healthspan. The geroscience hypothesis suggests that targeting the ageing process could prevent or delay multiple diseases, enhancing healthspan. Fucoidan, a sulfated polysaccharide from brown macroalgae, is a safe dietary supplement with Sirtuin-6 (SIRT6) activating properties, which are linked to longevity. Clinical studies have shown that it reduces inflammatory markers associated with biological aging and frailty and influences DNA methylation in vitro and in vivo; however, its effects on human DNA methylation remain unknown.
Trial Details
NCT Number NCT07500649
Lead Sponsor National University of Singapore
Collaborators: University of Rochester, L'Oreal, DoNotAge.org
Conditions Aging
Enrollment 60 participants
Start Date 2025-07-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-30